The role of lysine-specific demethylase 6A (KDM6A) in tumorigenesis and its therapeutic potentials in cancer therapy
LJ Chen, XY Xu, XD Zhong, YJ Liu, MH Zhu, F Tao… - Bioorganic …, 2023 - Elsevier
Histone demethylation is a key post-translational modification of chromatin, and its
dysregulation affects a wide array of nuclear activities including the maintenance of genome …
dysregulation affects a wide array of nuclear activities including the maintenance of genome …
Targeting histone demethylases as a potential cancer therapy
W Diao, J Zheng, Y Li, J Wang… - … Journal of Oncology, 2022 - spandidos-publications.com
Post‑translational modifications of histones by histone demethylases have an important role
in the regulation of gene transcription and are implicated in cancers. Recently, the family of …
in the regulation of gene transcription and are implicated in cancers. Recently, the family of …
The development and benefits of metformin in various diseases
Y Dong, Y Qi, H Jiang, T Mi, Y Zhang, C Peng, W Li… - Frontiers of …, 2023 - Springer
Metformin has been used for the treatment of type II diabetes mellitus for decades due to its
safety, low cost, and outstanding hypoglycemic effect clinically. The mechanisms underlying …
safety, low cost, and outstanding hypoglycemic effect clinically. The mechanisms underlying …
Low-Dose Metformin Treatment Reduces In Vitro Growth of the LL/2 Non-small Cell Lung Cancer Cell Line
Lung cancer maintains a relatively small survival rate (~ 19%) over a 5-year period and up to
80–85% of all lung cancer diagnoses are Non-Small Cell Lung Cancer (NSCLC). To …
80–85% of all lung cancer diagnoses are Non-Small Cell Lung Cancer (NSCLC). To …
Potential of [11C](R)-PK11195 PET Imaging for Evaluating Tumor Inflammation: A Murine Mammary Tumor Model
AM de Souza, CC Real, MS Junqueira… - Pharmaceutics, 2022 - mdpi.com
Background: Breast tumor inflammation is an immunological process that occurs mainly by
mediation of Tumor-Associated Macrophages (TAM). Aiming for a specific measurement of …
mediation of Tumor-Associated Macrophages (TAM). Aiming for a specific measurement of …
Epigenetics of cisplatin resistance
AM Baird, SG Gray - Epigenetic Cancer Therapy, 2023 - Elsevier
Cisplatin and carboplatin are the most commonly used cytotoxic chemotherapeutic agents to
treat cancer. These agents, usually combined with drugs, such as gemcitabine or …
treat cancer. These agents, usually combined with drugs, such as gemcitabine or …
Alpha lipoic acid diminishes migration and invasion in hepatocellular carcinoma cells through an AMPK-p53 axis
F Hidalgo, AC Ferretti, CB Etichetti, E Baffo, A Pariani… - 2023 - researchsquare.com
Hepatocellular carcinoma (HCC) associated with viral or metabolic liver diseases is a
growing cancer that lacks effective therapy. AMPK is downregulated in the early stages of …
growing cancer that lacks effective therapy. AMPK is downregulated in the early stages of …
Metformin sensitizes hepatocellular carcinoma to sorafenib by facilitating NHE1 degradation
G Tian, J Yu, L Yan, F Ye, Y Gui, J Li, S Yang, L Zou… - 2023 - researchsquare.com
Sorafenib is a first-line chemotherapy drug for advanced hepatocellular carcinoma (HCC),
but the drug resistance appeared over time. Hypoxia and acidosis are common features of …
but the drug resistance appeared over time. Hypoxia and acidosis are common features of …
ULOGA METFORMINA U TERAPIJI NESITNOĆELIJSKOG KARCINOMA PLUĆA
J Ljubičič, A Pešić, K Pavlović, SM Denčić… - Zdravstvena …, 2022 - aseestant.ceon.rs
Sažetak Nesitnoćelijski karcinom pluća (NSCLC) sačinjava 80-85% svih dijagnostikovanih
formi karcinoma pluća. Konvencionalni terapijski modaliteti pokazuju malu uspešnost u …
formi karcinoma pluća. Konvencionalni terapijski modaliteti pokazuju malu uspešnost u …
The role of metformin in the treatment of non-small cell lung cancer
J Ljubičić, A Pešić, K Pavlović, DS Misirlić… - Zdravstvena …, 2022 - data-scindeks.ceon.rs
Out of the all newly diagnosed lung cancers, non-small cell lung carcinoma (NSCLC)
comprises 80-85%. When treating advanced stages of the disease, conventional therapy …
comprises 80-85%. When treating advanced stages of the disease, conventional therapy …